Notice Pursuant to the National Cooperative Research and Production Act of 1993-Alliance for Water Stewardship, 65657-65658 [2010-26734]
Download as PDF
Federal Register / Vol. 75, No. 206 / Tuesday, October 26, 2010 / Notices
Section 6(b) of the Act on July 15, 2009
(74 FR 34364).
The last notification was filed with
the Department on July 13, 2010. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on August 18, 2010 (75 FR 51114).
Federal Register pursuant to Section
6(b) of the Act on June 27, 2008 (73 FR
36571).
DEPARTMENT OF JUSTICE
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Alliance for Water
Stewardship
[FR Doc. 2010–26737 Filed 10–25–10; 8:45 am]
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
BILLING CODE 4410–11–M
[FR Doc. 2010–26740 Filed 10–25–10; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–11–M
Antitrust Division
DEPARTMENT OF JUSTICE
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—ASTM International
Antitrust Division
emcdonald on DSK2BSOYB1PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—International SAE
Consortium Ltd.
Notice is hereby given that, on
September 21, 2010, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
International SAE Consortium Ltd.
(‘‘ISAEC’’) has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Amgen, Inc., Thousand
Oaks, CA; AstraZeneca UK Ltd.,
London, United Kingdom; Cerner
Corporation, Kansas City, MO; Clinical
Data, Inc., Newton, MA; and Merck
Sharp & Dohme Corp., Rahway, NJ, has
been added as parties to this venture.
Also, F. Hoffmann-La Roche, INC.,
Basel, Switzerland; Johnson & Johnson
Pharmaceutical Research &
Development, LLC, Raritan, NJ; and
Sanofi-Aventis, Bridgewater, NJ, have
withdrawn as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and ISAEC
intends to file additional written
notification disclosing all changes in
membership.
On September 27, 2007, ISAEC filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on November 7, 2007
(72 FR 62867).
The last notification was filed with
the Department of Justice on May 21,
2008. A notice was published in the
VerDate Mar<15>2010
18:09 Oct 25, 2010
Jkt 223001
65657
Notice is hereby given that, on
September 23, 2010, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), ASTM
International (‘‘ASTM’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing additions or
changes to its standards development
activities. The notifications were filed
for the purpose of extending the Act’s
provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, ASTM has provided an
updated list of current, ongoing ASTM
standards activities originating between
May 2010 and September 2010
designated as work items. A complete
listing of ASTM work items, along with
a brief description of each, is available
at https://www.astm.org.
On September 15, 2004, ASTM filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on November 10, 2004
(69 FR 65226).
The last notification was filed with
the Department on May 6, 2010. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on June 1, 2010 (75 FR 30440).
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. 2010–26736 Filed 10–25–10; 8:45 am]
BILLING CODE 4410–11–M
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Antitrust Division
Notice is hereby given that, on
September 10, 2010, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Alliance for Water Stewardship (‘‘AWS’’)
has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing (1) the name and
principal place of business of the
standards development organization
and (2) the nature and scope of its
standards development activities. The
notifications were filed for the purpose
of invoking the Act’s provisions limiting
the recovery of antitrust plaintiffs to
actual damages under specified
circumstances.
Pursuant to Section 6(b) of the Act,
the name and principal place of
business of the standards development
organization is: Alliance for Water
Stewardship, Arlington, VA. The nature
and scope of AWS’s standards
development activities are: (1) To
establish equitable, voluntary,
transparent, science-based standards for
socially beneficial and environmentally
sustainable use and management of
fresh water at the watershed level; (2) to
promote use and management of fresh
water which will maintain or improve
biodiversity and ecological processes
and secure longterm benefits for local
peoples and society at large; and (3) to
encourage effective governance for
water use and management through
voluntary certification of businesses and
water service providers. The AWS is
responsible for coordinating and
overseeing the process of developing
water use and management target
standards and indicators, such as
catchment flow volume, user
abstraction, nutrients in effluents,
sediments in effluents, temperature of
effluents, water pricing, and other
aspects of a voluntary water
stewardship standard system. As part of
its standards development activities, the
AWS organizes a Global Water
Roundtable and continent-level
Regional Initiatives, through which it
invites stakeholder organizations to
participate in the standards
development process. The AWS will
hold the intellectual property resulting
from its standards development
activities until such a time when it may
E:\FR\FM\26OCN1.SGM
26OCN1
65658
Federal Register / Vol. 75, No. 206 / Tuesday, October 26, 2010 / Notices
transfer its holdings to a successor
organization or is itself designated the
permanent custodian of the intellectual
property.
Below is the name and contact
information of an individual from
whom additional information
concerning the organization can be
obtained: Carey R. Ramos, Esq.; Paul,
Weiss, Rifkind, Wharton & Garrison
LLP; 1285 Avenue of the Americas; New
York, NY 10019–6064.
Dated: October 19, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator,Office of
Diversion Control,Drug Enforcement
Administration.
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
Importer of Controlled Substances;
Notice of Application
[FR Doc. 2010–26734 Filed 10–25–10; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled
Substances;Notice of Application
This is notice that on July 22, 2010,
Cody Laboratories Inc., 601 Yellowstone
Avenue, Cody, Wyoming 82414–9321,
made application by renewal to the
Drug Enforcement Administration
(DEA) for registration as an importer of
the basic classes of controlled
substances listed in schedule II:
Drug
Schedule
emcdonald on DSK2BSOYB1PROD with NOTICES
Raw Opium (9600) .......................
Concentrate of Poppy Straw
(9670).
II
II
The company plans to import narcotic
raw materials for manufacturing and
further distribution to its customers.
The company is registered with DEA as
a manufacturer of several controlled
substances that are manufactured from
raw opium, poppy straw, and
concentrate of poppy straw.
As explained in the Correction to
Notice of Application pertaining to
Rhodes Technologies, 72 FR 3417
(2007), comments and requests for
hearings on applications to import
narcotic raw material are not
appropriate.
As noted in a previous notice
published in the Federal Register on
September 23, 1975, (40 FR 43745), all
applicants for registration to import a
basic class of any controlled substances
in schedule I or II are, and will continue
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
VerDate Mar<15>2010
18:09 Oct 25, 2010
Jkt 223001
[FR Doc. 2010–27023 Filed 10–25–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on July 12, 2010, Noramco, Inc.,
Division of Ortho-McNeil, Inc., 500
Swedes Landing Road, Wilmington,
Delaware 19801, made application by
renewal to the Drug Enforcement
Administration (DEA) for registration as
an importer of the basic classes of
controlled substances listed in schedule
II:
Drug
Schedule
Raw Opium (9600) .......................
Concentrate of Poppy Straw
(9670).
Tapentadol (9780) ........................
II
II
II
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than November 26, 2010.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to
21U.S.C. 958(a); 21 U.S.C. 823(a); and
21 CFR 1301.34(b), (c), (d), (e), and (f)
are satisfied.
Dated: October 19, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator,Office of
Diversion Control,Drug Enforcement
Administration.
[FR Doc. 2010–27025 Filed 10–25–10; 8:45 am]
BILLING CODE 4410–09–P
The company plans to import the Raw
Opium (9600) and Concentrate of Poppy
Straw (9670) to manufacture other
controlled substances. The company
plans to import Tapentadol (9780) in
intermediate form for the bulk
manufacture of Tapentadol (9780)
which it will distribute to its customers.
No comments, objections, or requests
for any hearings will be accepted on any
application for registration or reregistration to import crude opium,
poppy straw, concentrate of poppy
straw, and coca leaves. As explained in
the Correction to Notice of Application
pertaining to Rhodes Technologies, 72
FR 3417 (2007), comments and requests
for hearings on applications to import
narcotic raw material are not
appropriate.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act [21 U.S.C.
952(a)(2)(B)] may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on July 12 2010,
Aldrich Chemical Company Inc., DBA
Isotec, 3858 Benner Road, Miamisburg,
Ohio 45342–4304, made application by
renewal to the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Ibogaine (7260) ............................
Tetrahydrocannabinols (7370) .....
2,5–Dimethoxyamphetamine
(7396).
Psilocyn (7438) .............................
Normorphine (9313) .....................
Acetylmethadol (9601) .................
Alphacetylmethadol except levo–
alphacetylmethadol (9603).
Normethadone (9635) ..................
Norpipanone (9636) .....................
3–Methylfentanyl (9813) ...............
E:\FR\FM\26OCN1.SGM
26OCN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
Agencies
[Federal Register Volume 75, Number 206 (Tuesday, October 26, 2010)]
[Notices]
[Pages 65657-65658]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-26734]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Alliance for Water Stewardship
Notice is hereby given that, on September 10, 2010, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Alliance for Water
Stewardship (``AWS'') has filed written notifications simultaneously
with the Attorney General and the Federal Trade Commission disclosing
(1) the name and principal place of business of the standards
development organization and (2) the nature and scope of its standards
development activities. The notifications were filed for the purpose of
invoking the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Pursuant to Section 6(b) of the Act, the name and principal place
of business of the standards development organization is: Alliance for
Water Stewardship, Arlington, VA. The nature and scope of AWS's
standards development activities are: (1) To establish equitable,
voluntary, transparent, science-based standards for socially beneficial
and environmentally sustainable use and management of fresh water at
the watershed level; (2) to promote use and management of fresh water
which will maintain or improve biodiversity and ecological processes
and secure longterm benefits for local peoples and society at large;
and (3) to encourage effective governance for water use and management
through voluntary certification of businesses and water service
providers. The AWS is responsible for coordinating and overseeing the
process of developing water use and management target standards and
indicators, such as catchment flow volume, user abstraction, nutrients
in effluents, sediments in effluents, temperature of effluents, water
pricing, and other aspects of a voluntary water stewardship standard
system. As part of its standards development activities, the AWS
organizes a Global Water Roundtable and continent-level Regional
Initiatives, through which it invites stakeholder organizations to
participate in the standards development process. The AWS will hold the
intellectual property resulting from its standards development
activities until such a time when it may
[[Page 65658]]
transfer its holdings to a successor organization or is itself
designated the permanent custodian of the intellectual property.
Below is the name and contact information of an individual from
whom additional information concerning the organization can be
obtained: Carey R. Ramos, Esq.; Paul, Weiss, Rifkind, Wharton &
Garrison LLP; 1285 Avenue of the Americas; New York, NY 10019-6064.
Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 2010-26734 Filed 10-25-10; 8:45 am]
BILLING CODE 4410-11-M